From: Clinicopathologic characteristics of SALL4-immunopositive hepatocellular carcinoma
SALL4(+) HCC (n=47) | SALL4(−) HCC (n=290) | P value | |
---|---|---|---|
Age (years, mean±SD) | 59.2±13.1 | 65.2±10.4 | <0.001 |
Sex (male:female) | 26:21 | 237:53 | <0.001 |
HBV positive | 20 (42.6%) | 54 (18.6%) | <0.001 |
HCV positive | 20 (42.6%) | 162 (55.9%) | 0.086 |
HBV/HCV negative | 7 (14.9%) | 77 (26.6%) | 0.087 |
Diabetes mellitus (+) | 6 (12.8%) | 80 (27.6%) | 0.031 |
History of alcohol intakea (+) | 5 (42.8%) | 71 (24.5%) | 0.038 |
Body mass index≥25 (kg/m2) | 2/25 (8.0%)b | 38/147 (25.9%)b | 0.070 |
TP (g/dl, mean±SD) | 7.05±0.50 | 7.13±0.59 | 0.356 |
ALB (g/dl, mean±SD) | 3.74±0.44 | 3.74±0.42 | 0.996 |
ChE (IU/l, mean±SD) | 232.1±78.9 | 224.7±75.7 | 0.536 |
AST (IU/l, mean±SD) | 40.8±23.8 | 48.6±38.4 | 0.191 |
ALT (IU/l, mean±SD) | 42.4±26.6 | 44.2±29.3 | 0.694 |
TB (mg/dl, mean±SD) | 0.69±0.29 | 0.77±0.30 | 0.099 |
PT (%, mean±SD) | 82.4±11.8 | 79.9±12.5 | 0.206 |
Plt (×104/μl, mean±SD) | 18.8±9.2 | 17.7±7.2 | 0.379 |
ICG15 (%, mean±SD) | 10.9±6.7 | 15.8±9.4 | <0.001 |
Child-Pugh (A/B) | 44/3 | 253/37 | 0.328 |
AFP (ng/ml, median [IQR]) | 3976.5 (25580.8) | 14.0 (124.5) | <0.001 |
PIVKA2 (mAu/ml, median [IQR]) | 349.5 (1937.3) | 66.0 (567.3) | 0.014 |
Preoperative treatmentc (no/yes) | 29/18 | 176/114 | 0.895 |
Liver cirrhosis (no/yes) | 28/19 | 181/105e | 0.626 |
Steatosisd (absent/present) | 38/9 | 185/101e | 0.029 |